Traws Pharma, Inc. — Director's Dealing 2024

Aug 7, 2024

SEC Form 4/A — Form 4/A

Issuer: Traws Pharma, Inc. (TRAW)
CIK: 0001130598
Period of Report: 2024-04-01

Reporting Person: Dukes Iain D. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-04-01	Common Stock	A	67500	—	Acquired	134187	Direct

Footnotes

F1: On April 3, 2024, the reporting person filed a Form 4 that inadvertently reported the number of shares of common stock (the "Common Stock") of Traws Pharma, Inc. (f/k/a Onconova Therapeutics, Inc.) underlying a grant of restricted stock units as 67,550 instead of 67,500. Nevertheless, the number of shares of Common Stock beneficially owned following the reported transaction was correctly reported in the original Form 4 as 134,187.

F2: Represents an award of restricted stock units that will vest in four equal annual installments beginning April 1, 2025. Each restricted stock unit will convert into shares of Common Stock on a one-for-one basis.